Selumetinib for NF2-Related Schwannomatosis

Clinical trial NCT07707947 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07707947
Sponsor: Beijing Tiantan Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neurofibromatosis Type 2 NF2 NF2-related Schwannomatosis Meningioma Ependymoma Vestibular Schwannoma

Start date: 2026-07-15
Primary completion: 2028-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.